Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:30 am Sale | 2022-12-30 | 13G | Ovid Therapeutics Inc. OVID | The Vanguard Group | 2,581,736 3.660% | -860,882 (-25.01%) | Filing History |
| 2023-02-03 11:50 am Unchanged | 2022-06-21 | 13G | Ovid Therapeutics Inc. OVID | Takeda Pharmaceutical Company Limited | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-03 11:48 am Purchase | 2022-07-01 | 13G | Ovid Therapeutics Inc. OVID | Takeda Pharmaceutical Company Limited | 8,781,996 12.200% | 7,000,000 (+392.82%) | Filing History |
| 2022-02-14 5:29 pm Sale | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | During Matthew | 3,103,932 4.500% | -916,862 (-22.80%) | Filing History |
| 2022-02-14 4:31 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 6,554,770 9.400% | 462,500 (+7.59%) | Filing History |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital, LLC | 6,082,200 8.900% | 6,082,200 (New Position) | Filing History |
| 2022-02-11 5:47 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | Stonepine Capital Management, LLC | 4,006,185 5.900% | 506,185 (+14.46%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | The Vanguard Group | 3,442,618 5.060% | 3,442,618 (New Position) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Ovid Therapeutics Inc. OVID | BlackRock Inc. BLK | 1,202,730 1.800% | -2,209,003 (-64.75%) | Filing History |
| 2021-04-29 4:48 pm Purchase | 2021-04-20 | 13G | Ovid Therapeutics Inc. OVID | Stonepine Capital Management, LLC | 3,500,000 5.300% | 3,500,000 (New Position) | Filing History |
| 2021-04-15 4:11 pm Purchase | 2021-04-13 | 13G | Ovid Therapeutics Inc. OVID | BIOTECHNOLOGY VALUE FUND L P | 6,631,051 10.100% | 2,109,000 (+46.64%) | Filing History |
| 2021-03-09 2:31 pm Unchanged | 2021-03-04 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital Fund L.P. | 6,082,200 9.600% | 0 (Unchanged) | Filing History |
| 2021-03-09 1:19 pm Purchase | 2020-03-04 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital Fund L.P. | 6,082,200 9.600% | 6,082,200 (New Position) | Filing History |
| 2021-02-17 3:13 pm Sale | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | During Matthew | 4,020,794 6.300% | -964,811 (-19.35%) | Filing History |
| 2021-02-16 4:37 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 6,092,270 9.600% | 369,337 (+6.45%) | Filing History |
| 2021-02-16 2:22 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | Consonance Capital Management LP | 6,058,505 11.000% | 3,169,617 (+109.72%) | Filing History |
| 2021-02-12 4:18 pm Sale | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | BIOTECHNOLOGY VALUE FUND L P | 4,522,051 6.900% | -733,250 (-13.95%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | BlackRock Inc. BLK | 3,411,733 5.400% | 2,756,291 (+420.52%) | Filing History |
| 2021-01-05 3:12 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | SINGER JAMES R | 3,000,000 4.700% | 150,000 (+5.26%) | Filing History |